Sumitomo Mitsui DS Asset Management Company, Ltd - ISIS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Sumitomo Mitsui DS Asset Management Company, Ltd ownership history of ISIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2015$328,000
-29.8%
8,1240.0%0.01%
-26.7%
Q2 2015$467,000
-11.4%
8,124
-1.9%
0.02%
-6.2%
Q1 2015$527,0008,2780.02%
Other shareholders
ISIS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
BB BIOTECH AG 6,417,548$255,675,00013.66%
HWG Holdings LP 339,799$13,538,0008.73%
DOWLING & YAHNKE LLC 675,798$26,924,0003.78%
GARRISON BRADFORD & ASSOCIATES INC 99,300$3,956,0003.74%
WILLIAM HARRIS INVESTORS INC 283,834$11,308,0003.35%
SECTORAL ASSET MANAGEMENT INC 1,222,401$48,700,0002.10%
AVALON CAPITAL MANAGEMENT 49,999$1,992,0001.68%
PINNACLE ASSOCIATES LTD 2,016,369$80,332,0001.57%
PERKINS CAPITAL MANAGEMENT INC 48,515$1,933,0001.30%
NCM Capital Advisers, Inc. 31,100$1,239,0001.28%
View complete list of ISIS PHARMACEUTICALS INC shareholders